INDOCO — INDOCO REMEDIES Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹30.11bn
- IN₹36.45bn
- IN₹18.17bn
- 62
- 26
- 33
- 31
Annual cashflow statement for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 286 | 1,320 | 2,366 | 1,928 | 1,243 |
| Depreciation | |||||
| Non-Cash Items | 287 | 366 | 81.7 | 503 | 457 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -52.4 | -1,595 | -1,499 | -1,348 | -1,160 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,228 | 822 | 1,738 | 1,788 | 1,458 |
| Capital Expenditures | -585 | -768 | -1,253 | -2,073 | -4,273 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 25.3 | 102 | 39.2 | -9.22 | -65.3 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -559 | -667 | -1,214 | -2,082 | -4,338 |
| Financing Cash Flow Items | -223 | -232 | -150 | -272 | -361 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -639 | -299 | -444 | 228 | 2,804 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 29.7 | -143 | 80.5 | -65.3 | -76 |